FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073457844> ?p ?o ?g. }

• W2073457844 endingPage "908" @default.
• W2073457844 startingPage "903" @default.
• W2073457844 abstract "Caspofungin is a new antifungal drug of the echinocandin class. We analyzed the clinical efficacy of caspofungin (50 mg/day) in the treatment of HIV-infected adults with endoscopically documented Candida esophagitis and enrolled in four clinical trials of caspofungin. Symptoms were evaluated daily; a favorable outcome required complete resolution of all esophageal symptoms assessed at the time of discontinuation of therapy. Relapse was defined as recurrent symptoms during the subsequent 2 weeks. A multivariate logistic regression model was developed to identify potential factors (including severity of symptoms at presentation, CD4(+) cell count on entry, extent of disease [assessed endoscopically at baseline], causative Candida species, duration of therapy [overall and after resolution of symptoms], time on treatment before symptom resolution, and antifungal prophylaxis) that might predict symptomatic relapse in the 2 weeks following completion of therapy. The median CD4(+) lymphocyte count for the entire population was 31/mm(3). Candida albicans was isolated from 109 of 110 patient samples cultured for the pathogen and constituted the sole isolate in 77%. Extensive esophageal involvement was present in 55% of patients at the time of pretreatment endoscopy. The duration of therapy ranged from 7 to 20 days (median, 12 days). Symptoms resolved in 117 of 123 patients (95%; 95% confidence interval, 90-98%) with a median time of ~4 days. Response rates were 43 of 46 (93%) and 70 of 73 (96%) for patients with greater or fewer than 50 CD4(+) cells/mm(3), and 80 of 85 (94%) and 23 of 24 (96%) in infections caused by C. albicans alone or in association with non-albicans isolates, respectively. Symptoms recurred within 2 weeks of stopping caspofungin in 19 of 115 evaluable patients (17%), including 3 of 16 (19%) receiving antifungal prophylaxis. Relapse rates were similar for patients with greater or fewer than 50 CD4(+) cells/mm(3). In this relatively small number of patients, only symptom severity and extent of disease judged endoscopically at baseline were significantly (p < 0.10) associated with early relapse in the multivariate model." @default.
• W2073457844 created "2016-06-24" @default.
• W2073457844 creator A5000268660 @default.
• W2073457844 creator A5046811864 @default.
• W2073457844 creator A5058093571 @default.
• W2073457844 creator A5062571783 @default.
• W2073457844 date "2002-09-01" @default.
• W2073457844 modified "2023-10-16" @default.
• W2073457844 title "Response and Relapse Rates of Candidal Esophagitis in HIV-Infected Patients Treated with Caspofungin" @default.
• W2073457844 cites W1614953311 @default.
• W2073457844 cites W1893975279 @default.
• W2073457844 cites W1908633066 @default.
• W2073457844 cites W2011613010 @default.
• W2073457844 cites W2015859713 @default.
• W2073457844 cites W2024503935 @default.
• W2073457844 cites W2037636618 @default.
• W2073457844 cites W2041457471 @default.
• W2073457844 cites W2059681057 @default.
• W2073457844 cites W2073316207 @default.
• W2073457844 cites W2100275023 @default.
• W2073457844 cites W2101712227 @default.
• W2073457844 cites W2108751484 @default.
• W2073457844 cites W2111029458 @default.
• W2073457844 cites W2114055030 @default.
• W2073457844 cites W2121373447 @default.
• W2073457844 cites W2125940292 @default.
• W2073457844 cites W2133244753 @default.
• W2073457844 cites W2142281465 @default.
• W2073457844 cites W2143449612 @default.
• W2073457844 cites W2143553359 @default.
• W2073457844 cites W2156228013 @default.
• W2073457844 cites W2166427367 @default.
• W2073457844 cites W2918285974 @default.
• W2073457844 doi "https://doi.org/10.1089/088922202760265579" @default.
• W2073457844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12230933" @default.
• W2073457844 hasPublicationYear "2002" @default.
• W2073457844 type Work @default.
• W2073457844 sameAs 2073457844 @default.
• W2073457844 citedByCount "37" @default.
• W2073457844 countsByYear W20734578442012 @default.
• W2073457844 countsByYear W20734578442013 @default.
• W2073457844 countsByYear W20734578442014 @default.
• W2073457844 countsByYear W20734578442015 @default.
• W2073457844 countsByYear W20734578442018 @default.
• W2073457844 countsByYear W20734578442023 @default.
• W2073457844 crossrefType "journal-article" @default.
• W2073457844 hasAuthorship W2073457844A5000268660 @default.
• W2073457844 hasAuthorship W2073457844A5046811864 @default.
• W2073457844 hasAuthorship W2073457844A5058093571 @default.
• W2073457844 hasAuthorship W2073457844A5062571783 @default.
• W2073457844 hasConcept C126322002 @default.
• W2073457844 hasConcept C141071460 @default.
• W2073457844 hasConcept C16005928 @default.
• W2073457844 hasConcept C203014093 @default.
• W2073457844 hasConcept C2778715236 @default.
• W2073457844 hasConcept C2779134260 @default.
• W2073457844 hasConcept C2779320740 @default.
• W2073457844 hasConcept C2779548794 @default.
• W2073457844 hasConcept C2779629538 @default.
• W2073457844 hasConcept C2779920096 @default.
• W2073457844 hasConcept C2780402444 @default.
• W2073457844 hasConcept C2780651595 @default.
• W2073457844 hasConcept C2780727368 @default.
• W2073457844 hasConcept C2780908437 @default.
• W2073457844 hasConcept C2780917455 @default.
• W2073457844 hasConcept C2781005205 @default.
• W2073457844 hasConcept C2908647359 @default.
• W2073457844 hasConcept C3013748606 @default.
• W2073457844 hasConcept C43270747 @default.
• W2073457844 hasConcept C54355233 @default.
• W2073457844 hasConcept C71924100 @default.
• W2073457844 hasConcept C86803240 @default.
• W2073457844 hasConcept C90924648 @default.
• W2073457844 hasConcept C99454951 @default.
• W2073457844 hasConceptScore W2073457844C126322002 @default.
• W2073457844 hasConceptScore W2073457844C141071460 @default.
• W2073457844 hasConceptScore W2073457844C16005928 @default.
• W2073457844 hasConceptScore W2073457844C203014093 @default.
• W2073457844 hasConceptScore W2073457844C2778715236 @default.
• W2073457844 hasConceptScore W2073457844C2779134260 @default.
• W2073457844 hasConceptScore W2073457844C2779320740 @default.
• W2073457844 hasConceptScore W2073457844C2779548794 @default.
• W2073457844 hasConceptScore W2073457844C2779629538 @default.
• W2073457844 hasConceptScore W2073457844C2779920096 @default.
• W2073457844 hasConceptScore W2073457844C2780402444 @default.
• W2073457844 hasConceptScore W2073457844C2780651595 @default.
• W2073457844 hasConceptScore W2073457844C2780727368 @default.
• W2073457844 hasConceptScore W2073457844C2780908437 @default.
• W2073457844 hasConceptScore W2073457844C2780917455 @default.
• W2073457844 hasConceptScore W2073457844C2781005205 @default.
• W2073457844 hasConceptScore W2073457844C2908647359 @default.
• W2073457844 hasConceptScore W2073457844C3013748606 @default.
• W2073457844 hasConceptScore W2073457844C43270747 @default.
• W2073457844 hasConceptScore W2073457844C54355233 @default.
• W2073457844 hasConceptScore W2073457844C71924100 @default.
• W2073457844 hasConceptScore W2073457844C86803240 @default.
• W2073457844 hasConceptScore W2073457844C90924648 @default.
• W2073457844 hasConceptScore W2073457844C99454951 @default.

• next